RO87387B - Procedeu pentru prepararea unor n2-acil-9-(1,3-dixidroxi-2-propoximetil)-guanine - Google Patents

Procedeu pentru prepararea unor n2-acil-9-(1,3-dixidroxi-2-propoximetil)-guanine

Info

Publication number
RO87387B
RO87387B RO112367A RO11236782A RO87387B RO 87387 B RO87387 B RO 87387B RO 112367 A RO112367 A RO 112367A RO 11236782 A RO11236782 A RO 11236782A RO 87387 B RO87387 B RO 87387B
Authority
RO
Romania
Prior art keywords
acyl
carbon atoms
propoxymethyl
dihydroxy
degrees
Prior art date
Application number
RO112367A
Other languages
English (en)
Romanian (ro)
Other versions
RO87387A (ro
Inventor
P. Julien Verheyden
C. John Martin
Original Assignee
Syntex Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23017790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RO87387(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Usa Inc filed Critical Syntex Usa Inc
Publication of RO87387A publication Critical patent/RO87387A/ro
Publication of RO87387B publication Critical patent/RO87387B/ro

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
RO112367A 1981-05-21 1982-05-20 Procedeu pentru prepararea unor n2-acil-9-(1,3-dixidroxi-2-propoximetil)-guanine RO87387B (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06267210 US4355032B2 (en) 1981-05-21 1981-05-21 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent

Publications (2)

Publication Number Publication Date
RO87387A RO87387A (ro) 1985-08-31
RO87387B true RO87387B (ro) 1985-08-31

Family

ID=23017790

Family Applications (2)

Application Number Title Priority Date Filing Date
RO112367A RO87387B (ro) 1981-05-21 1982-05-20 Procedeu pentru prepararea unor n2-acil-9-(1,3-dixidroxi-2-propoximetil)-guanine
RO107610A RO84860B (ro) 1981-05-21 1982-05-20 Procedeu pentru prepararea 9-(1, 3-dihidroxi-2-propeximetil)-guaninei

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO107610A RO84860B (ro) 1981-05-21 1982-05-20 Procedeu pentru prepararea 9-(1, 3-dihidroxi-2-propeximetil)-guaninei

Country Status (33)

Country Link
US (1) US4355032B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0066208B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JPS57203086A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR890004663B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR244227A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE15899T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU572086B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR8202931A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (3) CA1305139C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (4) CS235042B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD203052A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3266644D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK150304C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (7) ES512414A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI73682C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR76459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK67088A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU186514B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE53731B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL65836A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN156469B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU88334I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8700793A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (2) NL930022I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (2) NO161740C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ200691A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH17975A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (4) PL136637B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT74934B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (2) RO87387B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG81687G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1176841A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA823532B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4508898A (en) * 1980-09-16 1985-04-02 Ogilvie Kelvin K Antiviral triazine compounds
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4507305A (en) * 1981-05-21 1985-03-26 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
KR880002276B1 (ko) * 1981-08-11 1988-10-21 더 웰컴 화운데이션 리미티드 항비루스성 화합물의 제조방법
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
IE830186L (en) * 1982-02-01 1983-08-01 Syntex Inc Purines
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
DE3583858D1 (de) * 1984-12-12 1991-09-26 Syntex Inc Derivate von alcoxymethylaether und alcoxymethylester.
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
CA2005815C (en) * 1988-12-19 1999-08-03 Wellcome Foundation Limited (The) Antiviral acyclic nucleoside derivatives
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
CA2165419C (en) * 1993-06-23 1999-03-02 Jeffrey S. Sabol Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US6083953A (en) * 1994-07-28 2000-07-04 Syntex (U.S.A.) Inc. 2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) * 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
IN179493B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
EP0976751A1 (en) * 1996-04-09 2000-02-02 Lupin Laboratories Limited A process for the isomerisation of an N-7 isomer into an N-9 isomer useful in the synthesis of acyclic nucleosides
US5852208A (en) * 1996-08-30 1998-12-22 Dixie Chemical Company, Inc. Method of producing compounds containing acyloxyalkoxy groups from alcohols
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
AU2003274410A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Pharmaceutical compositions of ganciclovir
AU2003278420A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
US7078524B2 (en) * 2002-11-22 2006-07-18 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
JP4996241B2 (ja) * 2003-01-14 2012-08-08 ギリアード サイエンシーズ, インコーポレイテッド 組み合わせ抗ウイルス治療のための組成物および方法
ITMI20031202A1 (it) * 2003-06-13 2004-12-14 Lyogen Ltd Forma di cristallina del ganciclovir
CN1860120A (zh) * 2003-08-28 2006-11-08 兰贝克赛实验室有限公司 无定形盐酸缬更昔洛韦
JP4746866B2 (ja) * 2004-11-19 2011-08-10 Tcm株式会社 キャリッジ用ガタ抑制装置
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
US20110059921A1 (en) * 2008-03-27 2011-03-10 Ektar Therapeutics Oligomer-Nitrogenous Base Conjugates
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
WO2010075517A2 (en) * 2008-12-23 2010-07-01 Pharmasset, Inc. Nucleoside analogs
AR074977A1 (es) 2008-12-23 2011-03-02 Pharmasset Inc Sintesis de nucleosidos de purina
TW201026715A (en) * 2008-12-23 2010-07-16 Pharmasset Inc Nucleoside phosphoramidates
CN101851239B (zh) * 2009-04-03 2012-11-28 上海益威实业有限公司 一种更昔洛韦的回收方法
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
WO2012154698A2 (en) * 2011-05-06 2012-11-15 Mckenna Charles E Method to improve antiviral activity of nucleotide analogue drugs
CN102627643B (zh) * 2012-04-10 2014-01-08 常州康丽制药有限公司 更昔洛韦的精制方法
EP2912047B1 (en) 2012-10-29 2016-08-24 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
JP6237779B2 (ja) * 2012-11-03 2017-11-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害薬
CN103059023B (zh) * 2012-12-31 2015-09-30 浙江车头制药股份有限公司 一种制备更昔洛韦晶型ⅱ的方法
US9486530B1 (en) 2013-08-30 2016-11-08 Exela Pharma Sciences, LLC Ganciclovir compositions and related methods
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113476413B (zh) * 2021-08-09 2022-06-28 海南海灵化学制药有限公司 一种注射用更昔洛韦钠冻干粉的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
AU7938482A (en) * 1980-12-22 1982-07-20 Astra Lakemedel Aktiebolag Novel derivatives of guanine
KR880002276B1 (ko) * 1981-08-11 1988-10-21 더 웰컴 화운데이션 리미티드 항비루스성 화합물의 제조방법

Also Published As

Publication number Publication date
SG81687G (en) 1989-07-07
ES8507549A1 (es) 1985-09-16
AU8389282A (en) 1982-11-25
GR76459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-08-10
FI73682C (fi) 1987-11-09
DK227782A (da) 1982-11-22
ZA823532B (en) 1983-03-30
PL236521A1 (en) 1984-01-02
DK150304C (da) 1988-01-04
RO84860A (ro) 1984-09-29
IE821210L (en) 1982-11-21
IE53731B1 (en) 1989-02-01
NZ200691A (en) 1986-11-12
IN156469B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-08-10
ES8606869A1 (es) 1986-05-16
LU88334I2 (fr) 1994-09-09
KR830010112A (ko) 1983-12-26
US4355032B2 (en) 1990-10-30
ES8701496A1 (es) 1987-01-01
ES529383A0 (es) 1986-05-16
DE3266644D1 (en) 1985-11-07
SU1176841A3 (ru) 1985-08-30
CS235018B2 (en) 1985-04-16
ES8404355A1 (es) 1984-05-01
ES529384A0 (es) 1987-01-01
CS235044B2 (en) 1985-04-16
JPS57203086A (en) 1982-12-13
PT74934B (en) 1984-05-08
US4355032A (en) 1982-10-19
US4355032B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1983-06-14
BR8202931A (pt) 1983-05-03
ES8500276A1 (es) 1984-11-01
NL930022I1 (nl) 1993-05-03
FI73682B (fi) 1987-07-31
DK504183A (da) 1983-11-03
ATE15899T1 (de) 1985-10-15
CS235043B2 (en) 1985-04-16
DK149001C (da) 1988-11-28
HK67088A (en) 1988-09-02
PL136579B1 (en) 1986-02-28
PL242101A1 (en) 1984-07-16
RO87387A (ro) 1985-08-31
ES524899A0 (es) 1985-09-16
CA1305139C (en) 1992-07-14
PL136004B1 (en) 1986-01-31
IL65836A (en) 1991-04-15
NO821676L (no) 1982-11-22
DK150304B (da) 1987-02-02
EP0066208B1 (en) 1985-10-02
ES524900A0 (es) 1985-11-16
JPH0529399B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-30
DK149001B (da) 1985-12-16
CA1305141C (en) 1992-07-14
FI821794A0 (fi) 1982-05-20
NO161740C (no) 1989-09-20
ES512414A0 (es) 1984-05-01
ES533821A0 (es) 1985-06-16
NO161740B (no) 1989-06-12
PT74934A (en) 1982-06-01
AU572086B2 (en) 1988-05-05
ES520849A0 (es) 1984-11-01
KR890004663B1 (ko) 1989-11-24
ES8601204A1 (es) 1985-11-16
PL136332B1 (en) 1986-02-28
JPH046195B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-02-05
CS235042B2 (en) 1985-04-16
HU188000B (en) 1986-03-28
DK504183D0 (da) 1983-11-03
RO84860B (ro) 1984-10-30
PL246770A1 (en) 1984-08-27
EP0066208A1 (en) 1982-12-08
NL930139I1 (nl) 1993-11-01
CA1305140C (en) 1992-07-14
ES8505681A1 (es) 1985-06-16
PH17975A (en) 1985-02-22
PL136637B1 (en) 1986-03-31
MY8700793A (en) 1987-12-31
DD213218A5 (de) 1984-09-05
DD203052A5 (de) 1983-10-12
PL242100A1 (en) 1984-04-24
NL930139I2 (nl) 1997-07-01
NO1994005I1 (no) 1994-07-29
HU186514B (en) 1985-08-28
AR244227A1 (es) 1993-10-29
JPH04217983A (ja) 1992-08-07
IL65836A0 (en) 1982-08-31

Similar Documents

Publication Publication Date Title
RO87387B (ro) Procedeu pentru prepararea unor n2-acil-9-(1,3-dixidroxi-2-propoximetil)-guanine
RO82370B (ro) Procedeu pentru prepararea unor derivati de 9-aminodibenzopiran
RO84426B (ro) Procedeu pentru prepararea unor derivati de pleuromutiliglicozida
RO84802B (ro) Procedeu pentru obtinerea unor (1-aril-ciclobutil)-alchilamine
AR247204A1 (es) Derivados de la 2-alquiloxiaminoalquiliden-ciclohexanodiona-1,3 de accion herbicida, las composiciones herbicidas que las contienen y procedimiento para preparar dichos derivados.
ES8303329A1 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaal- canoil o azaaralcanoil)-indolin-2-carboxilicos.
YU22598A (sh) Derivati 5'-dezoksi-citidina
AR247566A1 (es) Procedimiento para preparar nuevos analogos carbociclicos de adenosina utiles como inmunosupresores
GR3007144T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ATE60768T1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
RO83099B (ro) Procedeu pentru prepararea unei pirolidinone
AR247483A1 (es) Nuevas metafenilendiaminas trialcoxi-sustituidas, procedimiento de preparacion, composiciones tintoreas para el tenido por oxidacion de fibras queratinicas y en particular de los cabellos humanos
EA199700392A1 (ru) Способ получения n-метил-2-(3,4-диметоксифенил)этиламина
ES2052196T3 (es) Hidrogenolisis selectiva de derivados perhalogenados.
FI882894A0 (fi) Menetelmä 2-kinoksalinoliyhdisteen valmistamiseksi
ES8800694A1 (es) Procedimiento para la obtencion de conjugados de muramilpeptidos y correspondientes estereoisomeros que se derivan de la d-manosa o d-galactosa.
RO84911B (ro) Procedeu pentru prepararea unor 1, 1-alcandioli carboxilati
DK37790D0 (da) Indolderivater, deres fremstilling og anvendelse
RO81223B (ro) Procedeu pentru prepararea unor derivati ai acidului 1-(cicloxenil)-4-aril-piperidincarboxilic
DK487087A (da) Fremgangsmaade til fremstilling af et saccharosederivat
AR246321A1 (es) Nuevos colorantes y procedimiento para su obtencion.
RO85278B (ro) Procedeu de preparare a unor derivati de 1, 2, 3-tiadiazol-5-il-uree
DE59205849D1 (de) Verfahren zur Herstellung von 8-N,N-Dialkylaminotricyclo-(5.2.1.0 2,6)decan
RO81210B (ro) Procedeu pentru prepararea unor derivati de 1, 2, 4-oxadiazina
MX174199B (es) Procedimiento para la hidrogenolisis selectiva de derivados perhalogenados del etano